Sunday 18 October 2026
Export CYPH’s income statement to Excel — free account
Cypherpunk Technologies Inc.
CYPH Healthcare Biotechnology
In the quarter to June 2026, EPS grew 152.5% and free cash flow grew 15.5%, each against the same quarter a year earlier.
2.57
0.45
−14.90%
Follow CYPH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(196.76%) | 5.11% | (108.18%) | (1.21%) | |
| (132.94%) | 4.54% | (93.10%) | (1.08%) | ||
ROIC |
0.00% | (18.40%) | (24.11%) | (8.44%) | |
Return on Tangible Assets |
(2,832.33%) | 3.06% | (72.11%) | (0.65%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.27) | (0.66) | (0.20) | (0.11) | |
Free Cash Flow |
(52.79) | (43.90) | (32.85) | (21.06) | |
| Other line items | |||||
Cash ROIC |
(426.42%) | (26.20%) | (36.08%) | (14.33%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.02 | (0.51) | 0.00 | (1.71) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(47.05) | (1,711.12) | (1,198.68) | (740.62) | |
Operating CF/Net income |
1.04 | (9.10) | 0.58 | 24.01 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.27) | (0.66) | (0.20) | (0.11) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates